Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 31 | $2,574,569 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
07 Dec 2022 17:56 | VNDA | Vanda Pharmaceuticals Inc | MORAN KEVIN PATRICK | SVP, CFO & Treasurer | 06 Dec 2022 | Sale | 4,792 | 10.6066 | 50,827 | D |
07 Dec 2022 17:58 | VNDA | Vanda Pharmaceuticals Inc | POLYMEROPOULOS MIHAEL HRISTOS | President and CEO | 06 Dec 2022 | Sale | 48,250 | 10.6131 | 512,082 | D |
07 Dec 2022 17:58 | VNDA | Vanda Pharmaceuticals Inc | POLYMEROPOULOS MIHAEL HRISTOS | President and CEO | 05 Dec 2022 | Sale | 47,650 | 10.6233 | 506,200 | D |
16 Dec 2022 16:38 | VNDA | Vanda Pharmaceuticals Inc | WILLIAMS TIMOTHY | SVP & General Counsel | 15 Dec 2022 | Sale | 8,000 | 7.0087 | 56,070 | D |
06 Mar 2023 18:24 | VNDA | Vanda Pharmaceuticals Inc | BIRZNIEKS GUNTHER | SVP, Business Development | 03 Mar 2023 | Sale | 8,268 | 6.264 | 51,791 | D |
06 Mar 2023 18:24 | VNDA | Vanda Pharmaceuticals Inc | BIRZNIEKS GUNTHER | SVP, Business Development | 02 Mar 2023 | Sale | 8,509 | 6.2044 | 52,793 | D |
06 Mar 2023 18:25 | VNDA | Vanda Pharmaceuticals Inc | MORAN KEVIN PATRICK | SVP, CFO & Treasurer | 03 Mar 2023 | Sale | 5,968 | 6.2833 | 37,499 | D |
06 Mar 2023 18:25 | VNDA | Vanda Pharmaceuticals Inc | MORAN KEVIN PATRICK | SVP, CFO & Treasurer | 02 Mar 2023 | Sale | 7,966 | 6.2573 | 49,846 | D |
06 Mar 2023 18:25 | VNDA | Vanda Pharmaceuticals Inc | POLYMEROPOULOS MIHAEL HRISTOS | President and CEO | 03 Mar 2023 | Sale | 22,538 | 6.2506 | 140,876 | D |
06 Mar 2023 18:25 | VNDA | Vanda Pharmaceuticals Inc | POLYMEROPOULOS MIHAEL HRISTOS | President and CEO | 02 Mar 2023 | Sale | 22,426 | 6.2302 | 139,718 | D |
06 Mar 2023 18:26 | VNDA | Vanda Pharmaceuticals Inc | WIJKSTROM JOAKIM | SVP, Chief Marketing Officer | 03 Mar 2023 | Sale | 4,113 | 6.32 | 25,994 | D |
06 Mar 2023 18:26 | VNDA | Vanda Pharmaceuticals Inc | WIJKSTROM JOAKIM | SVP, Chief Marketing Officer | 02 Mar 2023 | Sale | 7,720 | 6.2335 | 48,123 | D |
06 Mar 2023 18:26 | VNDA | Vanda Pharmaceuticals Inc | WILLIAMS TIMOTHY | SVP & General Counsel | 03 Mar 2023 | Sale | 8,301 | 6.2507 | 51,887 | D |
06 Mar 2023 18:26 | VNDA | Vanda Pharmaceuticals Inc | WILLIAMS TIMOTHY | SVP & General Counsel | 02 Mar 2023 | Sale | 8,437 | 6.2445 | 52,685 | D |
15 Jun 2023 16:20 | VNDA | Vanda Pharmaceuticals Inc | WILLIAMS TIMOTHY | SVP & General Counsel | 13 Jun 2023 | Sale | 14,600 | 6.5585 | 95,754 | D |
20 Jun 2023 16:34 | VNDA | Vanda Pharmaceuticals Inc | MORAN KEVIN PATRICK | SVP, CFO & Treasurer | 15 Jun 2023 | Sale | 16,000 | 6.2944 | 100,710 | D |
01 Aug 2023 16:30 | VNDA | Vanda Pharmaceuticals Inc | MORAN KEVIN PATRICK | SVP, CFO & Treasurer | 28 Jul 2023 | Sale | 412 | 6.3 | 2,596 | D |
01 Aug 2023 16:30 | VNDA | Vanda Pharmaceuticals Inc | MORAN KEVIN PATRICK | SVP, CFO & Treasurer | 28 Jul 2023 | Sale | 1,800 | 6.305 | 11,349 | D |
11 Aug 2023 16:36 | VNDA | Vanda Pharmaceuticals Inc | MITCHELL STEPHEN RAY | Director | 10 Aug 2023 | Sale | 6,500 | 6.0537 | 39,349 | D |
23 Aug 2023 16:23 | VNDA | Vanda Pharmaceuticals Inc | WIJKSTROM JOAKIM | SVP, Chief Marketing Officer | 21 Aug 2023 | Sale | 3,724 | 5.84 | 21,748 | D |
06 Mar 2024 16:46 | VNDA | Vanda Pharmaceuticals Inc | BIRZNIEKS GUNTHER | SVP, Business Development | 05 Mar 2024 | Sale | 8,684 | 4.1322 | 35,884 | D |
06 Mar 2024 16:46 | VNDA | Vanda Pharmaceuticals Inc | BIRZNIEKS GUNTHER | SVP, Business Development | 04 Mar 2024 | Sale | 8,727 | 4.2964 | 37,495 | D |
06 Mar 2024 16:46 | VNDA | Vanda Pharmaceuticals Inc | MORAN KEVIN PATRICK | SVP, CFO & Treasurer | 05 Mar 2024 | Sale | 8,902 | 4.2025 | 37,411 | D |
06 Mar 2024 16:46 | VNDA | Vanda Pharmaceuticals Inc | MORAN KEVIN PATRICK | SVP, CFO & Treasurer | 04 Mar 2024 | Sale | 5,798 | 4.4812 | 25,982 | D |
06 Mar 2024 16:47 | VNDA | Vanda Pharmaceuticals Inc | POLYMEROPOULOS MIHAEL HRISTOS | President and CEO | 05 Mar 2024 | Sale | 24,288 | 4.1285 | 100,273 | D |
06 Mar 2024 16:47 | VNDA | Vanda Pharmaceuticals Inc | POLYMEROPOULOS MIHAEL HRISTOS | President and CEO | 04 Mar 2024 | Sale | 30,884 | 4.2438 | 131,066 | D |
06 Mar 2024 16:48 | VNDA | Vanda Pharmaceuticals Inc | WIJKSTROM JOAKIM | SVP, Chief Marketing Officer | 05 Mar 2024 | Sale | 9,229 | 4.2074 | 38,830 | D |
06 Mar 2024 16:48 | VNDA | Vanda Pharmaceuticals Inc | WIJKSTROM JOAKIM | SVP, Chief Marketing Officer | 04 Mar 2024 | Sale | 7,498 | 4.4133 | 33,091 | D |
06 Mar 2024 16:50 | VNDA | Vanda Pharmaceuticals Inc | WILLIAMS TIMOTHY | SVP & General Counsel | 05 Mar 2024 | Sale | 8,941 | 4.1825 | 37,396 | D |
06 Mar 2024 16:50 | VNDA | Vanda Pharmaceuticals Inc | WILLIAMS TIMOTHY | SVP & General Counsel | 04 Mar 2024 | Sale | 8,147 | 4.4086 | 35,917 | D |
29 Jul 2024 17:24 | VNDA | Vanda Pharmaceuticals Inc | MORAN KEVIN PATRICK | SVP, CFO & Treasurer | 29 Jul 2024 | Sale | 2,251 | 5.9203 | 13,327 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)